Atlas FDA

PKT

19 FDA 510(k) clearances · Product code

97 daysmedian time to decision
405 days90th percentile
19clearances measured

FDA profile

Official device name
Laser For Disruption Of Adipocyte Cells For Aesthetic Use
Device class
Class II (moderate risk)
Regulation
21 CFR 878.5400
Medical specialty
General, Plastic Surgery
Flags
GMP exempt
FDA definition
Laser intended for the disruption of adipocyte cells indicated for body contouring or reduction in circumference of body areas.
Adverse events (MAUDE)
2017: 10 · 2018: 16 · 2019: 13
Reports received by FDA, not confirmed device causation - volume tracks device popularity as much as risk.
Sort:Newest firstOldest first

Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free

RecordFirmDate
1060nm laser body slimming machine (K240658)Hebei JT Medical Co., Ltd.2024-05-13
ReBorn (1050nm) (K233962)Lightfective , Ltd.2024-04-16
DEKA PHYSIQ 360 (K231971)El.En S.P.A.2023-09-26
Diode Laser Body Sculpture Systems (K231131)Shanghai Bele Medical Technology Co.,Ltd2023-06-22
EON (K222226)Dominion Aesthetic Technologies, Inc.2023-02-17
Diosculpt (K222265)Shanghai Wonderful Opto-Electrics Tech.Co.,Ltd2022-09-23
EON (K211681)Dominion Aesthetic Technologies, Inc.2022-03-30
BodySculp (K212331)Rohrer Aesthetics, LLC2021-11-09
Powersculp laser lipolysis system (K211402)Lotuxs Medtech (Suzhou) Co., Ltd.2021-07-30
SLIMUS (K192970)Hironic Co., Ltd.2020-12-01
Diode Laser Body Sculpture System (K201731)Shanghai Apolo Medical Technology Co., Ltd.2020-09-10
Powersculp laser lipolysis system (K191068)Wuhan Lotuxs Technology Co., Ltd.2019-07-17
Eon FR (K180511)Dominion Aesthetic Technologies, Inc.2019-06-12
SculpSure (K182741)Cynosure2019-01-03
SculpSure (K171992)Cynosure, Inc.2017-09-26
Sculpsure (K171111)Cynosure, Inc.2017-06-13
SculpSure (K160470)Cynosure, Inc.2016-07-21
SculpSure (K150724)Cynosure, Inc.2015-07-01
SculpSure (K150230)Cynosure, Inc.2015-05-15

Track PKT automatically

Every clearance here is in the API, with alerts when new ones post.